Clinical Trials Browser

Immunotherapy, Adoptive × CNS × 90 days × Clear all

NCT06482905 2026-01-06

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Phase 1 Recruiting

Glioma